Yahoo Web Search

Search results

  1. Sep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines expected to be available in the coming days.

    • What You Need to Know
    • Recommendations for Everyone Aged 5 Years and Older
    • Recommendations for Children Aged 6 Months—4 Years
    • Recommendation for People Who May Get Additional Updated COVID-19 Vaccines
    • When Are You Up to Date?
    • How Well COVID-19 Vaccines Work
    • About COVID-19 Vaccines
    • Getting Vaccines If You Recently Had COVID-19
    • Vaccination Received Outside the United States

    •CDC recommends the 2023–2024 updated COVID-19 vaccines: Pfizer-BioNTech, Moderna, or Novavax, to protect against serious illness from COVID-19.

    •Everyone aged 5 years and older ‡ should get 1 dose of an updated COVID-19 vaccine to protect against serious illness from COVID-19.

    •Children aged 6 months–4 years need multiple doses of COVID-19 vaccines to be up to date, including at least 1 dose of updated COVID-19 vaccine.

    •People who are moderately or severely immunocompromised may get additional doses of updated COVID-19 vaccine.

    •COVID-19 vaccine recommendations will be updated as needed.

    •People who are up to date have lower risk of severe illness, hospitalization and death from COVID-19 than people who are unvaccinated or who have not completed the doses recommended for them by CDC.

    Children aged 5 years – 11 years who are not vaccinated or have gotten previous COVID-19 vaccine(s)

    Children aged 5 years – 11 years who are unvaccinated or have previously gotten a COVID-19 vaccine before September 12, 2023, should get 1 updated Pfizer-BioNTech or Moderna COVID-19 vaccine.

    People aged 12 years and older who are not vaccinated

    Moderna Novavax

    People aged 12 years and older who got previous COVID-19 vaccine(s)

    Vaccine Overview Learn more about COVID-19 vaccines Pfizer-BioNTech VaccineModerna VaccineNovavax Vaccine ‡12 years and older: People aged 12 years and older who have not previously gotten any COVID-19 vaccine doses and choose to get Novavax should get 2 doses of updated Novavax vaccine to be up to date.

    Children Who Are Not Vaccinated

    Pfizer-BioNTech Vaccine Overview Moderna Moderna Vaccine Overview

    Children Who Got Previous COVID-19 Vaccine(s)

    One Previous Dose Two or More Previous Doses Pfizer-BioNTech Vaccine Overview Moderna One Previous Dose Two or More Previous Doses Moderna Vaccine Overview

    People who are moderately or severely immunocompromised may get additional doses of updated COVID-19 vaccines. Talk to your healthcare provider about additional updated doses.

    Everyone aged 5 years and older

    You are up to date when you get 1 updated COVID-19 vaccine.‡

    Children aged 6 months—4 years

    You are up to date when you get all recommended doses, including at least 1 dose of updated COVID-19 vaccine.

    People who got the Johnson & Johnson/Janssen COVID-19 vaccine

    You are up to date when you get 1 updated COVID-19 vaccine.

    •People who are up to date have lower risk of severe illness, hospitalization and death from COVID-19 than people who are unvaccinated or who have not completed the doses recommended for them by CDC.

    •Additional updated COVID-19 vaccine doses can help restore protection that has decreased since previous vaccination.

    COVID-19 vaccines available in the United States are effective at protecting people from getting seriously ill, being hospitalized, and dying. As with other vaccine-preventable diseases, you are best protected from COVID-19 when you stay up to date with the recommended vaccinations.

    COVID-19 vaccines recommended for use in the United States:

    •Pfizer-BioNTech

    •Moderna

    If you recently had COVID-19, you still need to stay up to date with your vaccines, but you may consider delaying your vaccine by 3 months.

    Reinfection is less likely in the weeks to months after infection. However, certain factors could be reasons to get a vaccine sooner rather than later, such as:

    •personal risk of severe disease,

    •risk of disease in a loved one or close contact,

    •local COVID-19 hospital admission level,

    •and the most common COVID-19 variant currently causing illness.

    For Healthcare and Public Health

    Use of COVID-19 Vaccines in the United States: Interim Clinical Considerations Last Updated Jan. 18, 2024 Source: National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases

  2. Nov 1, 2023 · Information about Moderna COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and older.

    • 065208055
    • kathy.katella-cofrancesco@yale.edu
    • Why would another COVID vaccination help? The updated vaccines are not expected to prevent all cases of COVID, including those causing mild illness; rather, their aim is to reduce severe illness, hospitalization, and death from infection.
    • How is the updated COVID vaccine different from the previous one? The bivalent booster, which is no longer available, was introduced in the fall of 2022.
    • Why isn’t the new COVID vaccine considered a booster? The FDA is calling the new shots “updated vaccines” in anticipation of needing to provide updated formulas annually, similar to the flu shot, which changes each year.
    • How safe is the updated COVID vaccine? COVID vaccines are safe and effective, according to the CDC. The safety of COVID vaccines has been rigorously monitored and evaluated since their emergency use authorization (EUA) in December 2020.
  3. Feb 27, 2024 · The Vaccine study confirmed that the Moderna and Pfizer/BioNTech vaccines are linked in rare cases to myocarditis and pericarditis, conditions involving inflammation of the heart muscle and...

  4. Mar 27, 2024 · Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials. Announces next-generation COVID-19 vaccine candidate as fourth respiratory vaccine to successfully meet its Phase 3 endpoints. Expects two more Phase 3 readouts in 2024, including combination vaccine against flu and COVID-19, and vaccine against CMV.

  5. Sep 11, 2023 · FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...

  1. People also search for